Cardiologists Reevaluate Stroke Prevention Approaches for AFib Patients

LAAO devices emerge as alternative to blood thinners for certain high-risk individuals

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Cardiologists are reassessing strategies for preventing strokes in patients with atrial fibrillation (AFib), a common heart rhythm disorder affecting millions. While blood thinners have long been the standard of care, their limitations - including cost, adherence challenges, and bleeding risks - are prompting a closer look at alternative interventions like left atrial appendage occlusion (LAAO) devices.

Why it matters

AFib patients face a stroke risk 4-5 times higher than those without the condition. Blood thinners, while effective, carry inherent risks that make them unsuitable for some individuals. LAAO devices offer a promising alternative approach to stroke prevention that could benefit high-risk patients unable to safely take long-term blood thinner therapy.

The details

LAAO devices work by sealing off the left atrial appendage, a common site for clot formation in AFib patients. This prevents blood from pooling and reduces stroke risk without the need for lifelong blood thinners. Cardiologists emphasize the importance of evaluating LAAO device performance in real-world clinical practice to refine patient selection and optimize implantation techniques.

  • Approximately February 20, 2026, cardiologists are re-evaluating approaches to stroke prevention for AFib patients.

The players

Atman Shah, MD

A cardiologist at the University of Chicago Medicine who has been implanting LAAO devices for over 12 years.

Rahul Vasudev, MD

An interventional cardiologist at St. Joseph's Health who performs the WATCHMAN procedure, a minimally invasive LAAO treatment option.

Got photos? Submit your photos here. ›

What they’re saying

“The left atrial appendage is a lot like the appendix in our gut. We're not really sure what it does in adults, but it can cause a lot of problems. This device gives us a way to wall it off so clots can't form. Then patients don't have to take blood thinners, and their risk of stroke is lower.”

— Atman Shah, MD, Cardiologist (newsdirectory3.com)

“Patients don't have to navigate these decisions alone. A thorough evaluation and open communication with a cardiologist are essential to making informed choices about stroke prevention strategies in the context of AFib.”

— Rahul Vasudev, MD, Interventional Cardiologist (newsdirectory3.com)

What’s next

Ongoing research is crucial to further refine patient selection, optimize device technology, and assess long-term outcomes for LAAO devices. Cardiologists will continue to evaluate these devices in real-world settings to ensure their safety and effectiveness.

The takeaway

For AFib patients at high risk of stroke but unable to safely take long-term blood thinners, LAAO devices offer a promising alternative approach to stroke prevention. However, close collaboration with a cardiologist is essential to determine the most appropriate treatment plan for each individual's unique health needs and risk profile.